The neuroprotective effects of the angiotensin receptor antagonists are well documented in experimental cerebral ischemia [13], but their robust vascular protective effects [11, 17, 31] appear to be incompatible with the demonstrated ability to increase MMP-2 and MMP-9 activity [17]. This evidence concerns the gene MMP9 and brain ischemia.